[Federal Register Volume 70, Number 158 (Wednesday, August 17, 2005)]
[Notices]
[Page 48441]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-16288]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 25, 2005, and published in the Federal 
Register on April 4, 2005 (70 FR 17124-17125), Mallinckrodt Inc., 3600 
North Second Street, St. Louis, Missouri 63147, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed in Schedules I and II:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370).................................          I
Codeine-N-oxide (9053).......................................          I
Dihydromorphine (9145).......................................          I
Difenoxin (9168).............................................          I
Morphine-N-oxide (9307)......................................          I
Normorphine (9313)...........................................          I
Norlevorphanol (9634)........................................          I
Amphetamine (1100)...........................................         II
Methamphetamine (1105).......................................         II
Methylphenidate (1724).......................................         II
Codeine (9050)...............................................         II
Diprenorphine (9058).........................................         II
Etorphine HCL (9059).........................................         II
Dihydrocodeine (9120)........................................         II
Hydromorphone (9150).........................................         II
Oxycodone (9143).............................................         II
Diphenoxylate (9170).........................................         II
Benzoylecgonine (9180).......................................         II
Hydrocodone (9193)...........................................         II
Levorphanol (9220)...........................................         II
Meperidine (9230)............................................         II
Methadone (9250).............................................         II
Methadone Intermediate (9254)................................         II
Metopon (9260)...............................................         II
Dextropropoxyphene (9273)....................................         II
Morphine (9300)..............................................         II
Thebaine (9333)..............................................         II
Opium extracts (9610)........................................         II
Opium fluid extract (9620)...................................         II
Opium tincture (9630)........................................         II
Opium, powdered (9639).......................................         II
Opium, granulated (9640).....................................         II
Levo-alphacetylmethadol (9648)...............................         II
Oxymorphone (9652)...........................................         II
Noroxymorphone (9668)........................................         II
Alfentanil (9737)............................................         II
Remifentanil (9739)..........................................         II
Sufentanil (9740)............................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for internal use and for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Mallinckrodt Inc. to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Mallinckrodt Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: August 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-16288 Filed 8-16-05; 8:45 am]
BILLING CODE 4410-09-U